Archer Investment Corporation’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,350
Closed -$46.1K 847
2021
Q4
$46.1K Hold
1,350
0.02% 379
2021
Q3
$65.1K Buy
1,350
+365
+37% +$16.9K 0.02% 319
2021
Q2
$44.5K Buy
985
+200
+25% +$8.86K 0.02% 340
2021
Q1
$37.9K Buy
785
+185
+31% +$9.63K 0.02% 386
2020
Q4
$32.3K Hold
600
0.02% 376
2020
Q3
$22.1K Hold
600
0.01% 351
2020
Q2
$18.6K Sell
600
-541
-47% -$15K 0.01% 362
2020
Q1
$32K Hold
1,141
0.02% 276
2019
Q4
$33K Buy
+1,141
New +$27.2K 0.02% 325

Other funds holding NEO

Archer Investment Corporation's NEO Position: Q1 2022 in Review

Archer Investment Corporation sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 1,350 shares — an estimated $46.1K sold.

Archer Investment Corporation first reported a position in NEO in Q4 2019 and held it in 9 quarters. The position peaked at $65.1K in Q3 2021. 280 funds tracked by Wall St. Rank hold NEO as of Q1 2022.

  • Archer Investment Corporation reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
  • Archer Investment Corporation sold 1,350 NeoGenomics shares in Q1 2022, an estimated $46.1K.
  • Archer Investment Corporation first reported a position in NeoGenomics in Q4 2019 and held it in 9 quarters.
  • Archer Investment Corporation's NeoGenomics position peaked at $65.1K in Q3 2021.
  • 280 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.

Based on Archer Investment Corporation's 13F filing for Q1 2022, filed 12 May 2022.